These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 18613393

  • 1. Serum pepsinogens as an early diagnostic marker of H. pylori eradication.
    Shirai N, Furuta T, Sugimoto M, Kanaoka S, Watanabe F, Takashima M, Yamada M, Futami H, Sato Y, Kubota H, Kodaira M, Kajimura M, Maekawa M, Hishida A.
    Hepatogastroenterology; 2008; 55(82-83):486-90. PubMed ID: 18613393
    [Abstract] [Full Text] [Related]

  • 2. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 3. Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori.
    Furuta T, Kaneko E, Baba S, Arai H, Futami H.
    Am J Gastroenterol; 1997 Jan; 92(1):84-8. PubMed ID: 8995943
    [Abstract] [Full Text] [Related]

  • 4. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [Abstract] [Full Text] [Related]

  • 5. [Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
    Gisbert JP, Boixeda D, Vila T, de Rafael L, Alvarez Baleriola I, Martín de Argila C.
    Med Clin (Barc); 1995 Nov 04; 105(15):561-5. PubMed ID: 7500674
    [Abstract] [Full Text] [Related]

  • 6. [Investigation about usefulness of serum antibody of Helicobacter pylori and serum pepsinogen I/II ratio as a marker of the judgment after eradication therapy].
    Fujisawa T, Kumagai T, Goto A, Fujimori K, Akamatsu T, Kiyosawa K.
    Nihon Rinsho; 1999 Jan 04; 57(1):101-6. PubMed ID: 10036944
    [Abstract] [Full Text] [Related]

  • 7. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep 04; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

  • 8. [A decrease in the basal levels of serum pepsinogen I after H. pylori eradication].
    Boixeda D, Gisbert JP, Vila T, Cantón R, Redondo C, Martín de Argila C, Cano A, García Plaza A.
    Rev Clin Esp; 1995 Apr 04; 195(4):214-9. PubMed ID: 7784654
    [Abstract] [Full Text] [Related]

  • 9. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?
    Gisbert JP, Olivares D, Jimenez I, Pajares JM.
    Dig Liver Dis; 2006 Apr 04; 38(4):254-9. PubMed ID: 16309984
    [Abstract] [Full Text] [Related]

  • 10. An evaluation of a serologic test with a current infection marker of Helicobacter pylori before and after eradication therapy in Chinese.
    Wang XY, Yang Y, Shi RH, Ho B, Wang HD, Zhang GX.
    Helicobacter; 2008 Feb 04; 13(1):49-55. PubMed ID: 18205666
    [Abstract] [Full Text] [Related]

  • 11. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II.
    Matsukawa Y, Nishinarita S, Kaneko M, Takei M, Murakami M, Horie T, Kawamura F, Arakawa Y, Kuwayama H, Kurosaka H.
    Int J Clin Pharmacol Res; 1997 Feb 04; 17(4):127-32. PubMed ID: 9526173
    [Abstract] [Full Text] [Related]

  • 12. The effects of Helicobacter pylori eradication on body mass index and dyspeptic symptoms.
    Suto H, Yamazaki Y, Yoshida I, Yamakawa A, Ohtani M, Ito Y, Kuriyama M, Kato T, Azuma T.
    Digestion; 2009 Feb 04; 79(4):235-42. PubMed ID: 19401613
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
    Jung SW, Lee SW, Hyun JJ, Kim DI, Koo JS, Yim HJ, Park JJ, Lee HS, Chun HJ, Um SH, Choi JH, Kim CD, Ryu HS.
    Dig Liver Dis; 2009 Feb 04; 41(2):134-40. PubMed ID: 18436489
    [Abstract] [Full Text] [Related]

  • 14. Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan.
    Kawai T, Miki K, Ichinose M, Kenji Y, Miyazaki I, Kawakami K, Kataoka M, Yamagishi T, Sofuni A, Itoi T, Moriyasu F, Takagi Y, Aoki T, Matsubayashi J, Mukai K.
    Inflammopharmacology; 2007 Feb 04; 15(1):31-5. PubMed ID: 17323193
    [Abstract] [Full Text] [Related]

  • 15. A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.
    Osumi H, Fujisaki J, Suganuma T, Horiuchi Y, Omae M, Yoshio T, Ishiyama A, Tsuchida T, Miki K.
    PLoS One; 2017 Feb 04; 12(8):e0183980. PubMed ID: 28854276
    [Abstract] [Full Text] [Related]

  • 16. Serum pepsinogen I levels and acid secretion in Helicobacter pylori associated enlarged fold gastritis.
    Yasunaga Y, Shinomura Y, Kanayama S, Miyazaki Y, Bonilla Palacios JJ, Matsuzawa Y.
    Ital J Gastroenterol; 1996 Feb 04; 28(8):457-61. PubMed ID: 9032589
    [Abstract] [Full Text] [Related]

  • 17. [Time course changes in morphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers].
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME.
    Ter Arkh; 2006 Feb 04; 78(2):26-31. PubMed ID: 16613092
    [Abstract] [Full Text] [Related]

  • 18. Serum pepsinogen C: a useful marker of Helicobacter pylori eradication?
    Plebani M, Basso D, Scrigner M, Toma A, Di Mario F, Dal Bò N, Samloff IM.
    J Clin Lab Anal; 1996 Feb 04; 10(1):1-5. PubMed ID: 8926560
    [Abstract] [Full Text] [Related]

  • 19. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
    Vakil N, Zullo A, Ricci C, Hassan C, Vaira D.
    Aliment Pharmacol Ther; 2008 Dec 01; 28(11-12):1304-8. PubMed ID: 18774949
    [Abstract] [Full Text] [Related]

  • 20. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication.
    Masaoka T, Suzuki H, Imaeda H, Hosoda H, Ohara T, Morishita T, Ishii H, Kangawa K, Hibi T.
    Hepatogastroenterology; 2005 Dec 01; 52(61):1-4. PubMed ID: 15782980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.